These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66. The drug treatment of duodenal ulcer: physiological considerations in the choice of therapy. Jones DB; Hunt RH Aust N Z J Med; 1986 Apr; 16(2):263-7. PubMed ID: 2875708 [No Abstract] [Full Text] [Related]
67. Effect of the pre-operative response to H2 receptor antagonists on the outcome of highly selective vagotomy for duodenal ulcer. Goodman AJ; Kerrigan DD; Johnson AG Br J Surg; 1987 Oct; 74(10):897-9. PubMed ID: 2889503 [TBL] [Abstract][Full Text] [Related]
68. Colloidal bismuth subcitrate and two different dosages of cimetidine in the treatment of resistant duodenal ulcer. Preliminary results. Bianchi Porro G; Parente F; Lazzaroni M; Pace F Scand J Gastroenterol Suppl; 1986; 122():39-41. PubMed ID: 2877490 [TBL] [Abstract][Full Text] [Related]
70. Implications of sucralfate-induced ulcer healing and relapse. Lam SK Am J Med; 1989 Jun; 86(6A):122-6. PubMed ID: 2660554 [TBL] [Abstract][Full Text] [Related]
71. Long term treatment of duodenal ulcer. A review of management options. Bianchi Porro G; Parente F Drugs; 1991 Jan; 41(1):38-51. PubMed ID: 1706986 [TBL] [Abstract][Full Text] [Related]
72. Protective drugs in the treatment of gastroduodenal ulcer disease. Koelz HR Scand J Gastroenterol Suppl; 1986; 125():156-64. PubMed ID: 3547612 [TBL] [Abstract][Full Text] [Related]